This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Centocor, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Michael Bardroff: Innovator in Anti-MCP-1 Antibodies
Introduction
Michael Bardroff is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of anti-MCP-1 antibodies. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Michael Bardroff holds a patent for "Anti-MCP-1 antibodies, compositions, methods and uses." This invention relates to at least one novel anti-MCP-1 antibody, including isolated nucleic acids that encode at least one anti-MCP-1 antibody, MCP-1, vectors, host cells, transgenic animals or plants, and methods of making and using thereof. The patent also encompasses therapeutic compositions, methods, and devices, highlighting the potential for medical advancements.
Career Highlights
Throughout his career, Bardroff has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Centocor, Inc. and Janssen Biotech, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Michael Bardroff has collaborated with esteemed colleagues, including Raymond W. Sweet and Anuk Das. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Michael Bardroff's contributions to the field of biotechnology, particularly through his patent on anti-MCP-1 antibodies, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in therapeutic applications.